BTZ-043 Dose Evaluation in Combination and Selection

Conditions:   Tuberculosis, Pulmonary;   Other Specified Pulmonary Tuberculosis Interventions:   Drug: BTZ-043;   Drug: Bedaquiline;   Drug: Delamanid;   Drug: Moxifloxacin Sponsors:   Michael Hoelscher;   Radboud University Medical Center;   University of California, San Francisco;   University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials